Health Care & Life Sciences » Biotechnology | Arno Therapeutics Inc.

Arno Therapeutics Inc.

Arno Therapeutics Inc.
Stock Exchange Other OTC
EPS
$0.44
Market Cap
$59.22 K
Shares Outstanding
49.35 M
Public Float
-

Profile

Address
200 Route 31 North
Flemington New Jersey 08822
United States
Employees -
Website http://www.arnothera.com
Updated 07/08/2019
Arno Therapeutics, Inc. operates as a biopharmaceutical company, which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs. It develops pre-clinical and clinical-stage product under the following brands: Onapristone, AR-42, and AR-12. The company was founded by Peter Morgan Kash, David M.

Financials

View All

Alexander A. Zukiwski
CEO, Principal Financial Officer & Director
Alexander A. Zukiwski
CEO, Principal Financial Officer & Director